Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,306 | 30,009 | -865 | -33,226 | -30,487 |
| Depreciation Amortization | 1,297 | 975 | 456 | 2,486 | 1,690 |
| Income taxes - deferred | -4,582 | 161 | -8,440 | -6,334 | 1,333 |
| Accounts receivable | 8,281 | 2,589 | -517 | 2,471 | 2,026 |
| Accounts payable and accrued liabilities | -4,051 | -1,550 | -1,187 | 4,641 | 259 |
| Other Working Capital | -9,478 | -13,814 | -8,463 | -10,484 | -11,650 |
| Other Operating Activity | -39,382 | -37,787 | 7,380 | 2,121 | 6,757 |
| Operating Cash Flow | $-29,609 | $-19,417 | $-11,636 | $-38,325 | $-30,072 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -94,179 | -82,162 | 13,226 | 38,598 | 33,428 |
| PPE Investments | -33 | N/A | N/A | 125 | 125 |
| Net Acquisitions | 17,250 | 14,500 | N/A | N/A | N/A |
| Investing Cash Flow | $-76,962 | $-67,662 | $13,226 | $38,723 | $33,553 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 179,500 | 179,516 | 62,210 | 118 | 123 |
| Other Financing Activity | 0 | 0 | 0 | -145 | -109 |
| Financing Cash Flow | $179,500 | $179,516 | $62,210 | $-27 | $14 |
| Exchange Rate Effect | 406 | -37 | -68 | 78 | 47 |
| Beginning Cash Position | 9,774 | 9,774 | 9,774 | 9,325 | 9,325 |
| End Cash Position | 83,109 | 102,174 | 73,506 | 9,774 | 12,867 |
| Net Cash Flow | $73,335 | $92,400 | $63,732 | $449 | $3,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,609 | -19,417 | -11,636 | -38,325 | -30,072 |
| Capital Expenditure | -33 | N/A | N/A | -29 | -29 |
| Free Cash Flow | -29,642 | -19,417 | -11,636 | -38,354 | -30,101 |